A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The majority of inherited retinal degenerations converge on the phenotype of photoreceptor cell death. Second- and third-order neurons are spared in these diseases, making it possible to restore retinal light responses using optogenetics. Viral expression of channelrhodopsin in the third-order neurons under ubiquitous promoters was previously shown to restore visual function, albeit at light intensities above illumination safety thresholds. Here, we report (to our knowledge, for the first time) activation of macaque retinas, up to 6 months post-injection, using channelrhodopsin-Ca 2+ -permeable channelrhodopsin (CatCh) at safe light intensities. High-level CatCh expression was achieved due to a new promoter based on the regulatory region of the gamma-synuclein gene (SNCG) allowing strong expression in ganglion cells across species. Our promoter, in combination with clinically proven adeno-associated virus 2 (AAV2), provides CatCh expression in peri-foveolar ganglion cells responding robustly to light under the illumination safety thresholds for the human eye. On the contrary, the threshold of activation and the proportion of unresponsive cells were much higher when a ubiquitous promoter (cytomegalovirus [CMV]) was used to express CatCh. The results of our study suggest that the inclusion of optimized promoters is key in the path to clinical translation of optogenetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.057 · Cited by 4,396
Independent optical excitation of distinct neural populations
Klapoetke, N. C., Murata, Y., Kim, S. S., Pulver, S. R., Birdsey-Benson, A., Cho, Y. K., Morimoto, T. K., Chuong, A. S., Carpenter, E. J., Tian, Z., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2836 · Cited by 2,344
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734 · cited 1×
“Several AAVs have been tested for retinal gene delivery via the intravitreal route, and some have evoked safety concerns that have not been fully addressed at this stage.(25,43) For example, a recent study suggested that the engineered AAV variant AAV2-7m8 might be more immunogenic when used at high doses via intravit…”
BackgroundSelf-citationInterim results from the international trial of Second Sight's visual prosthesis
Humayun, M. S., Dorn, J. D., da Cruz, L., Dagnelie, G., Sahel, J.-A., Stanga, P. E., Cideciyan, A. V., Duncan, J. L., Eliott, D., Filley, E., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.028 · Cited by 700
Self-citationBennett, J., Wellman, J., Marshall, K. A., McCague, S., Ashtari, M., DiStefano-Pappas, J., Elci, O. U., Chung, D. C., Sun, J., Wright, J. F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30371-3 · Cited by 461
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002865 · Cited by 395
Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey
Vandenberghe, L. H., Bell, P., Maguire, A. M., Cearley, C. N., Xiao, R., Calcedo, R., Wang, L., Castle, M. J., Maguire, A. C., Grant, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002103 · Cited by 242
Research works printed but not linked: 34
- Bessant, 2001, Molecular genetics and prospects for therapy of the inherited retinal dystrophies, Curr. Opin. Genet. Dev., 11, 307, 10.1016/S0959-437X(00)00195-7 · DOI
- Wright, 2010, Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait, Nat. Rev. Genet., 11, 273, 10.1038/nrg2717 · DOI · Paper page
- Humayun, 1999, Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa, Invest. Ophthalmol. Vis. Sci., 40, 143
- Jacobson, 2013, Retinal optogenetic therapies: clinical criteria for candidacy, Clin. Genet., 84, 175, 10.1111/cge.12165 · DOI
- Lorach, 2015, Photovoltaic restoration of sight with high visual acuity, Nat. Med., 21, 476, 10.1038/nm.3851 · DOI · Paper page
- Bi, 2006, Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, 50, 23, 10.1016/j.neuron.2006.02.026 · DOI · Paper page
- Lagali, 2008, Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat. Neurosci., 11, 667, 10.1038/nn.2117 · DOI · Paper page
- Greenberg, 2011, Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism, Neuron, 69, 713, 10.1016/j.neuron.2011.01.024 · DOI
- Pan, 2014, ChR2 mutants at L132 and T159 with improved operational light sensitivity for vision restoration, PLoS ONE, 9, e98924, 10.1371/journal.pone.0098924 · DOI
- Busskamp, 2010, Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, 329, 413, 10.1126/science.1190897 · DOI · Paper page
- Gaub, 2014, Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells, Proc. Natl. Acad. Sci. USA, 111, E5574, 10.1073/pnas.1414162111 · DOI · Paper page
- Sengupta, 2016, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol. Med., 8, 1248, 10.15252/emmm.201505699 · DOI · Paper page
- Doroudchi, 2011, Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol. Ther., 19, 1220, 10.1038/mt.2011.69 · DOI · Paper page
- Tomita, 2014, Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1, Mol. Ther., 22, 1434, 10.1038/mt.2014.81 · DOI · Paper page
- Macé, 2015, Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice, Mol. Ther., 23, 7, 10.1038/mt.2014.154 · DOI · Paper page
- Busskamp, 2011, Optogenetic approaches to restoring visual function in retinitis pigmentosa, Curr. Opin. Neurobiol., 21, 942, 10.1016/j.conb.2011.06.001 · DOI
- Cideciyan, 2008, Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics, Proc. Natl. Acad. Sci. USA, 105, 15112, 10.1073/pnas.0807027105 · DOI · Paper page
- Sugano, 2011, Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy, Gene Ther., 18, 266, 10.1038/gt.2010.140 · DOI
- Ivanova, 2010, Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina, Invest. Ophthalmol. Vis. Sci., 51, 5288, 10.1167/iovs.10-5389 · DOI · Paper page
- Kleinlogel, 2011, Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh, Nat. Neurosci., 14, 513, 10.1038/nn.2776 · DOI · Paper page
- Surgucheva, 2008, Gamma-synuclein as a marker of retinal ganglion cells, Mol. Vis., 14, 1540
- Quina, 2005, Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways, J. Neurosci., 25, 11595, 10.1523/JNEUROSCI.2837-05.2005 · DOI · Paper page
- Allen, 2017, Melanopsin contributions to the representation of images in the early visual system, Curr. Biol., 27, 1623, 10.1016/j.cub.2017.04.046 · DOI · Paper page
- Nussenblatt, 1985, Standardization of vitreal inflammatory activity in intermediate and posterior uveitis, Ophthalmology, 92, 467, 10.1016/S0161-6420(85)34001-0 · DOI · Paper page
- Nagel, 2003, Channelrhodopsin-2, a directly light-gated cation-selective membrane channel, Proc. Natl. Acad. Sci. USA, 100, 13940, 10.1073/pnas.1936192100 · DOI · Paper page
- Kleinlogel, 2011, A gene-fusion strategy for stoichiometric and co-localized expression of light-gated membrane proteins, Nat. Methods, 8, 1083, 10.1038/nmeth.1766 · DOI
- Izpisua Belmonte, 2015, Brains, genes, and primates, Neuron, 86, 617, 10.1016/j.neuron.2015.03.021 · DOI · Paper page
- Byrne, 2015, Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration, J. Clin. Invest., 125, 105, 10.1172/JCI65654 · DOI · Paper page
- Wu, 2006, Photochemical damage of the retina, Surv. Ophthalmol., 51, 461, 10.1016/j.survophthal.2006.06.009 · DOI · Paper page
- Lin, 2013, ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation, Nat. Neurosci., 16, 1499, 10.1038/nn.3502 · DOI · Paper page
- van Wyk, 2015, Restoring the ON switch in blind retinas: Opto-mGluR6, a next-generation, cell-tailored optogenetic tool, PLoS Biol., 13, e1002143, 10.1371/journal.pbio.1002143 · DOI · Paper page
- Gaub, 2015, Optogenetic vision restoration using rhodopsin for enhanced sensitivity, Mol. Ther., 23, 1562, 10.1038/mt.2015.121 · DOI · Paper page
- Choi, 2007, Production of recombinant adeno-associated viral vectors, Curr. Protoc. Mol. Biol., Chapter 12
- Aurnhammer, 2012, Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences, Hum. Gene Ther. Methods, 23, 18, 10.1089/hgtb.2011.034 · DOI · Paper page
Cited by
The Argus® II Retinal Prosthesis System
Luo, Y. H.-L., & da Cruz, L. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.09.003 · Cited by 351
Jüttner, J., Szabo, A., Gross-Scherf, B., Morikawa, R. K., Rompani, S. B., Hantz, P., Szikra, T., Esposti, F., Cowan, C. S., Bharioke, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0431-2 · Cited by 218
Roska, B., & Sahel, J.-A. (2018) · Nature · doi:10.1038/s41586-018-0076-4 · Cited by 161
Self-citationNext-generation AAV vectors—Do not judge a virus (only) by its cover
Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147
In vivo–directed evolution of adeno-associated virus in the primate retina
Byrne, L. C., Day, T. P., Visel, M., Strazzeri, J. A., Fortuny, C., Dalkara, D., Merigan, W. H., Schaffer, D. V., & Flannery, J. G. (2020) · JCI Insight · doi:10.1172/jci.insight.135112 · Cited by 104
Self-citationDosage thresholds and influence of transgene cassette in adeno-associated virus–related toxicity
Khabou, H., Cordeau, C., Pacot, L., Fisson, S., & Dalkara, D. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.144 · Cited by 93
Self-citationOptogenetic Light Sensors in Human Retinal Organoids
Garita-Hernandez, M., Guibbal, L., Toualbi, L., Routet, F., Chaffiol, A., Winckler, C., Harinquet, M., Robert, C., Fouquet, S., Bellow, S., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00789 · Cited by 65
Self-citationSystemic and local immune responses to intraocular AAV vector administration in non-human primates
Ail, D., Ren, D., Brazhnikova, E., Nouvel-Jaillard, C., Bertin, S., Mirashrafi, S. B., Fisson, S., & Dalkara, D. (2022) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2022.01.011 · Cited by 61
“Four animals had a ubiquitous CAG promoter, whereas 2 animals had a ganglion-cell-specific promoter, SNCG.29 Three out of the 4 animals with the ubiquitous promoter had a higher level of BABs post-injection compared with the 2 animals with the ganglion-cell-specific promoter (Figure S3).”
BackgroundSelf-citationNew Vision for Visual Prostheses
Farnum, A., & Pelled, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00036 · Cited by 58
Contemporary approaches to visual prostheses
Mirochnik, R. M., & Pezaris, J. S. (2019) · Military Medical Research · doi:10.1186/s40779-019-0206-9 · Cited by 58
Optical stimulation of neural tissue
Richardson, R. T., Ibbotson, M. R., Thompson, A. C., Wise, A. K., & Fallon, J. B. (2020) · Healthcare Technology Letters · doi:10.1049/htl.2019.0114 · Cited by 40
The argus ii retinal prosthesis system
Bloch, E., & da Cruz, L. (2020) · Prosthesis · doi:10.5772/intechopen.84947 · Cited by 31
Cao, X., Yung, J., Mak, H., & Leung, C. K. S. (2019) · Gene Therapy · doi:10.1038/s41434-019-0060-0 · Cited by 20
Metadata
- Authors
- Chaffiol, A., Caplette, R., Jaillard, C., Brazhnikova, E., Desrosiers, M., Dubus, E., Duhamel, L., Macé, E., Marre, O., Benoit, P., Hantraye, P., Bemelmans, A.-P., Bamberg, E., Duebel, J., Sahel, J.-A., Picaud, S., & Dalkara, D.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 25
- Issue
- 11
- Pages
- 2546-2560
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2738256613
- Cited by
- 152
- References
- 20
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 365 d)
- Funders
- Sanofi
- INSERM
- UPMC
- CNRS
- Fondation pour la Recherche Medicale
- Agence Nationale pour la Recherche Investissements d’Avenir Recherche Hospitalo-Univesritaire en santé
- RHU
- E-Rare Project
- OPTOREMODE
- Foundation Fighting Blindness (TA-GT-0911-0543-UPMC-WG)
- Fédération des Aveugles de France
- City of Paris
- Regional Council of Ile-de-France
- Agence Nationale de la Recherche (ANR-10-LABX-65)
- European Research Council
- ERC (309776)
- Deutsche Forschungsgemeinschaft (SFB 807)
- Max Planck Society
- NIH (U01NS090501)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.